Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

12:17pm IST
Change (% chg)

Rs-228.60 (-6.75%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for REDY.BO


Dr. Reddy's Laboratories Limited is an integrated global pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. Global Generics segment consists of its business of manufacturing and... (more)


Beta: 0.38
Market Cap(Mil.): Rs577,902.69
Shares Outstanding(Mil.): 170.59
Dividend: 20.00
Yield (%): 0.59


  REDY.BO Industry Sector
P/E (TTM): 164.70 31.45 34.04
EPS (TTM): 20.57 -- --
ROI: -- 15.44 14.66
ROE: -- 16.39 15.87
Search Stocks

BUZZ-India's Dr Reddy's slumps; US FDA releases details of warning letter

** US FDA releases details of warning letter (http://1.usa.gov/1QIDDeg)

9:24am IST

BUZZ-India's Dr Reddy's says adheres to all disclosure norms; stock recovers

** Dr Reddy's Laboratories' shares recover to trade 1 pct lower after falling as much as 6.8 pct intraday

19 Nov 2015

BUZZ-Indian drug makers attract short positions despite being oversold

** Indian drug makers attract short positions in derivatives even after being oversold

10 Nov 2015

BUZZ-Indian drug makers slump; US FDA scrutiny, weak earnings weigh

** Sun Pharmaceutical Industries slumps 5.3 pct, Dr.Reddy's Laboratories down 1.7 pct and Lupin falls 1.6 pct

09 Nov 2015

BUZZ-India's Dr.Reddy's slumps after US FDA warning letter

** Says API manufacturing facilities at including Srikakulam and Oncology formulation facility at Duvvada in Andhra Pradesh gets a warning letter from US FDA

06 Nov 2015

BUZZ-India's Dr.Reddy's falls; rival Torrent Pharma gets approval for key drug

** Rival Torrent Pharmaceuticals Ltd TORP.NS> gains 3.6 pct; gets U.S. FDA approval for generic version of AstraZeneca Plc's heartburn pill Nexium - U.S. FDA website

21 Oct 2015

BUZZ-Indian drugmakers up; CLSA says transition to complex drugs to drive re-rating

** Indian drugmakers' transition to making complex generics from simple should drive significant re-rating - CLSA

06 Aug 2015

BUZZ-India's Dr.Reddy's rises on generic drug launch

** Dr.Reddy's Laboratories rises as much as 1.9 pct to record high

14 Jul 2015

BUZZ-Australia's Alchemia hits record low

** Drug developer Alchemia Ltd slumps as much as 57.8 pct to a record low of A$0.035

29 May 2015

Earnings vs. Estimates

Search Stocks